Novartis Bioventures Ltd
CIK 1297709 · last filed 2020-06-22
Novartis Bioventures Ltd is a corporate insider who has filed 44 SEC Form 4 insider transactions across 11 companies since 2011. The most recent filing shows the insider sold $16.5M of GRTX on Jun 22, 2020. Across all open-market trades the lifetime net is −$22.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$29.12M
11
44
-$21.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics, Inc. (GRTX) Delisted | 10%+ Owner | 7,012,340 | $0.14 | $1.02M | -$11.18M | 4 | 2020-06-22 |
| BCYC | 10%+ Owner | 1,769,641 | $4.05 | $7.17M | $4.72M | 1 | 2019-05-30 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | 10%+ Owner | 4,188,508 | $33.00 | $138.22M | -$2.89M | 6 | 2019-04-29 |
| Rein Therapeutics, Inc. (ALRN) Delisted | 10%+ Owner | 2,100,004 | $2.11 | $4.43M | -$1.69M | 9 | 2019-04-02 |
| ALT | 10%+ Owner | 8,345,145 | $2.61 | $21.78M | $0 | 8 | 2018-09-14 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | 10%+ Owner | 2,175,314 | $12.01 | $26.13M | -$2.74M | 3 | 2018-05-14 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 2,254,677 | — | — | -$12.06M | 7 | 2017-06-20 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | 10%+ Owner | 4,493,458 | — | — | -$133.7K | 2 | 2015-07-17 |
| AKBA | 10%+ Owner | 182,590 | $0.92 | $168.8K | $3.10M | 1 | 2014-03-27 |
| Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | 10%+ Owner | 1,551,721 | — | — | $1.30M | 1 | 2014-02-06 |
| Adhera Therapeutics, Inc. (MRNAD) Delisted | 10%+ Owner | 2,560,565 | — | — | -$383.4K | 1 | 2011-01-27 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-22 | Galera Therapeutics, Inc. (GRTX) Delisted | Sell (S) | −2,004,424 | -$16.54M | EDGAR |
| 2020-06-17 | Galera Therapeutics, Inc. (GRTX) Delisted | Sell (S) | −38,772 | -$357.2K | EDGAR |
| 2020-06-04 | Galera Therapeutics, Inc. (GRTX) Delisted | Sell (S) | −29,930 | -$289.7K | EDGAR |
| 2019-11-12 | Galera Therapeutics, Inc. (GRTX) Delisted | Mixed | +7,086,134 | $6.00M | EDGAR |
| 2019-05-30 | BCYC | Mixed | +3,539,282 | $4.72M | EDGAR |
| 2019-04-29 | Whitehawk Therapeutics, Inc. (ARPO) Delisted | Sell (S) | −1,403,600 | -$1.45M | EDGAR |
| 2019-04-24 | Whitehawk Therapeutics, Inc. (ARPO) Delisted | Sell (S) | −102,114 | -$104.3K | EDGAR |
| 2019-04-15 | Whitehawk Therapeutics, Inc. (ARPO) Delisted | Sell (S) | −234,280 | -$245.4K | EDGAR |
| 2019-04-10 | Whitehawk Therapeutics, Inc. (ARPO) Delisted | Sell (S) | −401,492 | -$428.5K | EDGAR |
| 2019-04-02 | Rein Therapeutics, Inc. (ALRN) Delisted | Sell (S) | −254,300 | -$472.5K | EDGAR |